Income StatementBalance SheetCash FlowSegments
COA

Hemab Therapeutics Holdings, Inc. Common Stock Income Statement

Revenue, expenses, and profitability over time
Operating Income-$23.6MNet Income-$22.7MEps Diluted$-23.98

Operating Expenses

MetricQ1 '25Q1 '26
Other Operating Expense, Net$591.0K-$282.0K
Other operating income (expense), net$591.0K-$282.0K
Other operating expenses$16.6M$23.6M
Research and development$14.1M$19.5M
Other Operating Income$1.1M$937.0K
Selling, general and administrative$2.5M$4.2M
Total operating expenses$16.6M$23.6M

Operating Income

MetricQ1 '25Q1 '26
Other Operating Income$591.0K-$282.0K
Other operating income$1.1M$937.0K
Other Operating Income$1.1M$937.0K
Other operating income (expense), net$591.0K-$282.0K
Operating income-$16.6M-$23.6M

Other

MetricQ1 '25Q1 '26
OCI Unrealized Holding Gain (Loss) on Securities, Net of Tax$974.0K-$614.0K
Unrealized Gain (Loss) on Securities$974.0K-$614.0K
OCI Unrealized Holding Gain (Loss) on Securities, Net of Tax$974.0K-$614.0K
Comprehensive Income (Loss), Net of Tax, Attributable to Parent-$14.3M-$23.3M
Interest Income, Other$473.0K$1.2M
Net unrealized gains (losses) on securities still held$974.0K-$614.0K
Other income, net$591.0K-$282.0K
Other Comprehensive Income (Loss)-$14.3M-$23.3M

Earnings Per Share

MetricQ1 '25Q1 '26
Basic earnings per share$-16.18$-23.98
Diluted earnings per share$-16.18$-23.98
Weighted-average shares, basic946K946K
Weighted-average shares, diluted946K946K

Income Before Tax

MetricQ1 '25Q1 '26
Income before income taxes-$15.5M-$22.7M

Tax

MetricQ1 '25Q1 '26
Income tax expense-$190.0K$12.0K

Other Income & Expense

MetricQ1 '25Q1 '26
Interest income$473.0K$1.2M

Net Income

MetricQ1 '25Q1 '26
Net income-$15.3M-$22.7M